gynaecological cancers

Cervical cancer screening

Screening for cervical cancer involves regular cervical smear tests.


09:00 am – 06:00 pm
09:00 am – 06:00 pm
09:00 am – 06:00 pm
09:00 am – 06:00 pm
09:00 am – 06:00 pm


07595 927289

Among women aged between 35 and 64 years, the risk of cervical cancer is about 60–80% lower in women who are screened than in unscreened women, and the benefit increases with age. Overall, it is estimated that cervical cancer screening saves about 4500 lives each year.

Cervical smearing involves taking a small sample of cells from the surface of the cervix, which are then examined under a microscope to detect any abnormal cells. These abnormal cells are not cancer cells, but they could develop into cancer if they are left untreated. Depending on the result of the screening test, the cells may be tested for HPV. If abnormal cells are found in the screening test, you may be offered another test, called a colposcopy, to examine the cervix more closely. Depending on the results of this test, your doctor may suggest that the abnormal cells should be removed, which is usually done during a second colposcopy.


Colposcopy is an examination of the cervix using a special magnifying instrument called a colposcope. This is usually done when abnormal cells are found on a cervical smear test. Such cells are relatively common – occurring in about 1 in 10 cervical smear tests – and usually do not indicate a serious condition. However, it is important to rule out the possibility of cervical cancer, or to arrange treatment as soon as possible if cancer is present.

A colposcope may also be used to take a sample of tissue (a biopsy) from the cervix, or to remove any abnormal cells. The procedure takes about 10-15 minutes, and does not usually cause any pain, although taking a biopsy may cause some brief discomfort.

A colposcopy examination can be arranged through London Gynae Cancer Care in cases where abnormal cells are found in a cervical smear. We can also perform investigations, or arrange appropriate referrals, for women with symptoms that might indicate gynaecological cancers, such as irregular bleeding from the vagina, or unusual or changing lumps in the vulva.

Mr Rahul Nath


  • Biography
  • Awards
  • Publications

Rahul graduated in medicine from the University of Wales, and progressed his training in obstetrics and gynaecology in the West Midlands and in London.

He developed an interest in cancer early in his career. He completed a research project studying the immunology of human papillomavirus (HPV) infection of the cervix in normal women, those with abnormal cervical smears and with systemic lupus erythematosus at King’s College, London resulting in a MD degree.

Rahul trained as a specialist in gynaecological oncology and was appointed as a consultant gynaecological oncologist in 2006. He was lead clinician for gynaecology (2012 – 2014), and is presently clinical director for women’s services and joint clinical academic group lead for King’s Health Partners. He maintains a busy clinical practice.

  • Best Poster presentation, International Papillomavirus meeting, North Carolina 1999
  • Best Poster presentation, Combined British and  Dutch Gynaecological Cancer Meeting, Amsterdam 2000
  • Best Oral presentation, O&G trainees scientific presentations, 2002
  • CARE award for Clinical care, Guy’s and St Thomas Trust, 2011

Download a list of Mr Rahul Nath’s publications  (PDF 10Kb).

London Gynae Cancer Care

About one in every two people will be diagnosed with cancer at some time in their lives. The very thought of cancer can be overwhelming or even frightening, while the disease and its treatment can place great strain on both patients and their families and friends. Recognising this, London Gynae Cancer Care offers compassionate care, information and support to our patients and their families at all stages of their cancer journey.

But treating cancer isn’t the whole picture. At London Gynae Cancer Care, we also offer a range of services aimed at screening for cancer in women at risk, or diagnosing early cancer that has not yet spread (preinvasive cancer).

Terms Of Use | Privacy Policy | Cookie Policy.


The Lister Hospital


Located in the heart of London, London Gynae Cancer Care specialises in the management of gynaecological cancers such as ovarian, cervical or uterine cancer.

2018 All rights reserved.